CLASS II Device recall · Reported 6 Sep 2017 · FDA Enforcement Report

AirLife(TM) Reduced Heparin Arterial Blood Sampler recalled

Vyaire Medical is recalling AirLife(TM) Reduced Heparin Arterial Blood Sampler, distributed nationwide in the US. The recall was initiated on 18 Jul 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number 0001047501
Quantity recalled5,400 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3080-2017
FDA event ID
77845
Recalling firm
Vyaire Medical, Vernon Hills, IL
Classification
Class II
Status
Terminated
Recall initiated
18 Jul 2017
FDA classified
28 Aug 2017
Reported
6 Sep 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

18 Jul 2017Recall initiated by company
28 Aug 2017Classified by FDA+41 days
6 Sep 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lot #0001047501 of the 9025RHTR ABG sampling kits have been manufactured containing the incorrect sub-assembly which includes a larger needle (23 Gage, 1" needle), larger syringe (3mL), and larger amount of heparin (113IU), than what is intended for the kit.

Product as listed by the FDA

AirLife(TM) Reduced Heparin ARTERIAL BLOOD SAMPLER, REF 9025RHTR, 1ML SYRINE 25G 5/8", LUER SLIP PROTECTIVE SHEATH, 3.2 IU, STERILE R, Rx ONLY, CAREFUSION Lot #0001047501 of the 9025RHTR ABG sampling kits have been manufactured containing the incorrect sub-assembly which includes a larger needle (23 Gage, 1" needle), larger syringe (3mL), and larger amount of heparin (113IU), than what is intended for the kit.

Where it was distributed

Worldwide Distribution- Nationwide distribution to states of: FL, OK, VA, MI, TH, NM, MA, MO, WA, AND country of: Australia.

Nationwide FloridaMassachusettsMichiganMissouriNew MexicoOklahomaVirginiaWashington

Questions about this recall

Why was it recalled?

Lot #0001047501 of the 9025RHTR ABG sampling kits have been manufactured containing the incorrect sub-assembly which includes a larger needle (23 Gage, 1" needle), larger syringe (3mL), and larger amount of heparin (113IU), than what is intended for the kit.

Which lots are affected?

Lot Number 0001047501

Where was it sold?

Worldwide Distribution- Nationwide distribution to states of: FL, OK, VA, MI, TH, NM, MA, MO, WA, AND country of: Australia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Vyaire Medical

All 63

Other Syringes & Needles recalls

All 1,060